These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8586836)

  • 1. The metabolism of platelet-activating factor in severe and cerebral malaria.
    Davis TM; Binh TQ; van Phuong N; Sturm M; St John A; Dyer JR; Anh TK
    J Infect; 1995 Nov; 31(3):181-8. PubMed ID: 8586836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor and lipid metabolism in acute malaria.
    Davis TM; Sturm M; Zhang YR; Spencer JL; Graham RM; Li GQ; Taylor RR
    J Infect; 1993 May; 26(3):279-85. PubMed ID: 8505562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma platelet activating factor degradation and serum lipids after coronary bypass surgery.
    Stephens CJ; Graham RM; Yadava OP; Leong LL; Sturm MJ; Taylor RR
    Cardiovasc Res; 1992 Jan; 26(1):25-31. PubMed ID: 1516109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence and metabolism of lyso platelet-activating factor in human bone marrow.
    Denizot Y; Rougier F; Dupuis F; Trimoreau F; Dulery C; Laskar M; Praloran V
    J Lipid Mediat Cell Signal; 1997 May; 16(1):53-62. PubMed ID: 9101422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
    Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E
    Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of the lyso-derivative of platelet-activating factor are related to age.
    Taylor RR; Sturm M; Kendrew PJ; Vandongen R; Beilin LJ
    Clin Sci (Lond); 1989 Feb; 76(2):195-8. PubMed ID: 2924511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activating factor, lyso-platelet activating factor and arachidonic acid release in normal human skin and the influence of topical steroid treatment.
    Barr RM; Lawlor F; Judge MR; Courtney P; Barlow R; Kobza Black A; Mallet AI; Greaves MW
    Br J Clin Pharmacol; 1993 Jun; 35(6):637-41. PubMed ID: 8329291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the metabolism of lyso-platelet activating factor (lyso-PAF) in human paranasal sinus mucosa. The cultured ciliated epithelium can convert lyso-PAF to PAF.
    Inoue H; Ganbo T; Hisamatsu K; Ishida H
    Life Sci; 1993; 52(21):PL227-32. PubMed ID: 8502110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
    Milionis HJ; Elisaf MS; Karabina SA; Bairaktari E; Tselepis AD; Siamopoulos KC
    Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy.
    Tselepis AD; Goudevenos JA; Tambaki AP; Michalis L; Stroumbis CS; Tsoukatos DC; Elisaf M; Sideris DA
    Cardiovasc Res; 1999 Jul; 43(1):183-91. PubMed ID: 10536703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of platelet-activating factor, lyso-platelet-activating factor, and lysophosphatidylcholine on sperm motion: importance of albumin for motility stimulation.
    Jarvi K; Roberts KD; Langlais J; Gagnon C
    Fertil Steril; 1993 Jun; 59(6):1266-75. PubMed ID: 8495776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A competitive receptor binding assay for platelet-activating factor (PAF): quantification of PAF in rat brain.
    Tiberghien C; Laurent L; Junier MP; Dray F
    J Lipid Mediat; 1991; 3(3):249-66. PubMed ID: 1773028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA; Elisaf M; Bairaktari E; Tzallas C; Siamopoulos KC; Tselepis AD
    Eur J Clin Invest; 1997 Jul; 27(7):595-602. PubMed ID: 9263748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of the lyso-derivative of platelet-activating factor in acute severe systemic illness.
    Leonelli FM; Leong LL; Sturm MJ; Strophair JA; Clarke GM; Taylor RR
    Clin Sci (Lond); 1989 Nov; 77(5):561-6. PubMed ID: 2582728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet activating factor (PAF) and lyso-PAF in psoriasis.
    Judge MR; Barr RM; Mallet AI; Courtney F; Kobza Black A; Greaves MW
    Arch Dermatol Res; 1994; 286(7):376-9. PubMed ID: 7818279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.
    Chao W; Siafaka-Kapadai A; Hanahan DJ; Olson MS
    Biochem J; 1989 Jul; 261(1):77-81. PubMed ID: 2775221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocation of exogenous platelet-activating factor and its lyso-compound through plasma membranes is a rate-limiting step for their metabolic conversions into alkylacylglycerophosphocholines in rabbit platelets and guinea-pig leukocytes.
    Tokumura A; Tsutsumi T; Yoshida J; Tsukatani H
    Biochim Biophys Acta; 1990 May; 1044(1):91-100. PubMed ID: 2340312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue concentrations of platelet-activating factor in colorectal carcinoma: inverse relationships with Dukes' stage of patients.
    Denizot Y; Gainant A; Guglielmi L; Bouvier S; Cubertafond P; Mathonnet M
    Oncogene; 2003 Oct; 22(46):7222-4. PubMed ID: 14562051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor and human thyroid cancer.
    Denizot Y; Chianéa T; Labrousse F; Truffinet V; Delage M; Mathonnet M
    Eur J Endocrinol; 2005 Jul; 153(1):31-40. PubMed ID: 15994743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of platelet-activating factor by rat alveolar macrophages: lyso-PAF as an obligatory intermediate in the formation of alkylarachidonoyl glycerophosphocholine species.
    Robinson M; Snyder F
    Biochim Biophys Acta; 1985 Oct; 837(1):52-6. PubMed ID: 4052436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.